Press release Archives - Page 3 of 3 - Artios Pharma

Artios Pharma Announces $84 million (£65 million) Series B Financing

10 August 2018 | Press release

Article-6-400×400

Artios exercises option to in-license potential first-in-class nuclease development programme

8 March 2018 | Press release

Article-7-400×400

Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors

26 February 2018 | Press release

pierre

Artios Pharma wins Life Science Young Company of the Year and UK Private Finance Raise at the Biotech and Money Annual Awards 2017

15 September 2017 | Press release

Article-2-400×400

Artios Pharma appoints Dr Graeme Smith as Chief Scientific Officer

4 September 2017 | Press release

Graeme

Artios signs research collaboration with Masaryk University to develop novel cancer treatments targeting DNA nucleases in the DDR

12 June 2017 | Press release

Article-6-400×400

Artios announces formation of world-leading Scientific Advisory Board

8 June 2017 | Press release

cube-hero-front-300×300

Artios Strengthens Management Team with the Appointment of Dr Simon Boulton as Vice President Science Strategy

2 November 2016 | Press release

simon

Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies

21 September 2016 | Press release

Article-3-400×400

« Previous 1 2 3

© Artios Pharma 2023 | Website by Granite 5

Terms & conditions | Privacy policy | Site map